Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates
摘要:
Oleanolic and ursolic acid derived hydroxamates were easily obtained from their parent compounds; they were screened for their cytotoxicity applying SRB assays employing several human tumor cell lines. Low EC50 values were determined for compounds in which the nitrogen as well as the oxygen in the hydroxamic acid part still holds acidic hydrogens. Thus, ursolic acid derived compounds having at least an OH and/or NH moiety in the hydroxamate part of the molecule showed good cytotoxicity but they are significantly less selective for the tumor cells than oleanolic acid derived compounds. Good results were determined for oleanolic acid derived 7 for tumor cell lines 518A2 (melanoma, EC50 = 3.3 mu M), A2780 (ovarian carcinoma, EC50 = 3.4 mu M) and HT29 (colon adenocarcinoma, EC50 = 5.6 mu M) while being significantly less cytotoxic for fibroblasts (EC50 = 20.4 mu M). (C) 2015 Elsevier Ltd. All rights reserved.
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates
摘要:
Oleanolic and ursolic acid derived hydroxamates were easily obtained from their parent compounds; they were screened for their cytotoxicity applying SRB assays employing several human tumor cell lines. Low EC50 values were determined for compounds in which the nitrogen as well as the oxygen in the hydroxamic acid part still holds acidic hydrogens. Thus, ursolic acid derived compounds having at least an OH and/or NH moiety in the hydroxamate part of the molecule showed good cytotoxicity but they are significantly less selective for the tumor cells than oleanolic acid derived compounds. Good results were determined for oleanolic acid derived 7 for tumor cell lines 518A2 (melanoma, EC50 = 3.3 mu M), A2780 (ovarian carcinoma, EC50 = 3.4 mu M) and HT29 (colon adenocarcinoma, EC50 = 5.6 mu M) while being significantly less cytotoxic for fibroblasts (EC50 = 20.4 mu M). (C) 2015 Elsevier Ltd. All rights reserved.
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates
作者:Jana Wiemann、Lucie Heller、René Csuk
DOI:10.1016/j.bmcl.2015.12.064
日期:2016.2
Oleanolic and ursolic acid derived hydroxamates were easily obtained from their parent compounds; they were screened for their cytotoxicity applying SRB assays employing several human tumor cell lines. Low EC50 values were determined for compounds in which the nitrogen as well as the oxygen in the hydroxamic acid part still holds acidic hydrogens. Thus, ursolic acid derived compounds having at least an OH and/or NH moiety in the hydroxamate part of the molecule showed good cytotoxicity but they are significantly less selective for the tumor cells than oleanolic acid derived compounds. Good results were determined for oleanolic acid derived 7 for tumor cell lines 518A2 (melanoma, EC50 = 3.3 mu M), A2780 (ovarian carcinoma, EC50 = 3.4 mu M) and HT29 (colon adenocarcinoma, EC50 = 5.6 mu M) while being significantly less cytotoxic for fibroblasts (EC50 = 20.4 mu M). (C) 2015 Elsevier Ltd. All rights reserved.
Triterpenoid Hydroxamates as HIF Prolyl Hydrolase Inhibitors
Pentacyclic triterpenoid acids (PCTTAs) are pleiotropic agents that target many macromolecular endpoints with low to moderate affinity. To explore the biological space associated with PCTTAs, we have investigated the carboxylate-to-hydroxamate transformation, discovering that it de-emphasizes affinity for the transcription factors targeted by the natural compounds (NF-kappa B, STAT3, Nrf2, TGRS) and selectively induces inhibitory activity on HIF prolyl hydrolases (PHDs). Activity was reversible, isoform-selective, dependent on the hydroxamate location, and negligible when this group was replaced by other chelating elements or O-alkylated. The hydroxamate of betulinic acid (Sb) was selected for further studies, and evaluation of its effect on HIF-la expression under normal and hypoxic conditions qualified it as a promising lead structure for the discovery of new candidates in the realm of neuroprotection.